ATE261125T1 - Erkennung von tmorspezifische genprodukte - Google Patents

Erkennung von tmorspezifische genprodukte

Info

Publication number
ATE261125T1
ATE261125T1 AT98924666T AT98924666T ATE261125T1 AT E261125 T1 ATE261125 T1 AT E261125T1 AT 98924666 T AT98924666 T AT 98924666T AT 98924666 T AT98924666 T AT 98924666T AT E261125 T1 ATE261125 T1 AT E261125T1
Authority
AT
Austria
Prior art keywords
detection
specific gene
gene products
tmo
chromosomal aberrations
Prior art date
Application number
AT98924666T
Other languages
English (en)
Inventor
Paulus Benjamin Berendes
Janine Nicole Veenman
Denderen Adriana Cornelia Van
Ewijk Willem Van
Original Assignee
Univ Erasmus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus filed Critical Univ Erasmus
Application granted granted Critical
Publication of ATE261125T1 publication Critical patent/ATE261125T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98924666T 1997-05-20 1998-05-20 Erkennung von tmorspezifische genprodukte ATE261125T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201507 1997-05-20
PCT/NL1998/000289 WO1998053317A1 (en) 1997-05-20 1998-05-20 Recognition of tumour-specific gene products in cancer

Publications (1)

Publication Number Publication Date
ATE261125T1 true ATE261125T1 (de) 2004-03-15

Family

ID=8228328

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98924666T ATE261125T1 (de) 1997-05-20 1998-05-20 Erkennung von tmorspezifische genprodukte

Country Status (10)

Country Link
US (1) US6610498B1 (de)
EP (1) EP0983510B1 (de)
AT (1) ATE261125T1 (de)
AU (1) AU7677198A (de)
CA (1) CA2290656C (de)
DE (1) DE69822149T2 (de)
DK (1) DK0983510T3 (de)
ES (1) ES2217558T3 (de)
PT (1) PT983510E (de)
WO (1) WO1998053317A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686165B2 (en) * 1997-05-20 2004-02-03 Erasmus Universiteit Rotterdam Recognition of tumor-specific gene products in cancer
WO2002044719A1 (en) * 2000-11-29 2002-06-06 Statens Serum Institut A screening assay for detecting chromosome rearrangements or recombinations
DK1565746T3 (da) 2002-11-07 2011-01-10 Univ Erasmus Fremgangsmåde og prober til detektion af et tumor-specifikt fusionsprotein
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
US7242330B2 (en) * 2003-12-17 2007-07-10 Texas Instruments Incorporated Dynamic compensation of analog-to-digital converter (ADC) offset errors using filtered PWM
US20050214301A1 (en) * 2004-03-24 2005-09-29 Cell Signaling Technology, Inc. Antibodies specific for BCR-ABL fusion protein and uses thereof
DE212006000071U1 (de) * 2005-11-18 2008-07-24 Board of Regents, The University of Texas System, Austin Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
RU2558797C2 (ru) * 2009-10-20 2015-08-10 Нестек С.А. Способы выявления онкогенных слитых белков, основанные на анализе близкого взаимного расположения
US20120065092A1 (en) 2010-09-14 2012-03-15 Wai Hobert Fusion analyte cytometric bead assay, and systems and kits for performing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
US5447837A (en) * 1987-08-05 1995-09-05 Calypte, Inc. Multi-immunoassay diagnostic system for antigens or antibodies or both
AU6882791A (en) * 1989-11-22 1991-06-13 Children's Hospital Of Los Angeles Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia
DE69133528T2 (de) * 1990-06-27 2006-09-07 Princeton University Proteinkomplex p53/p90
WO1992021032A1 (en) * 1991-05-24 1992-11-26 The Regents Of The University Of California Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients
EP0604560B1 (de) * 1991-09-20 2004-08-11 Fred Hutchinson Cancer Research Center Menschliches cyclin e
FR2691475B1 (fr) * 1992-05-20 1995-03-24 Centre Nat Rech Scient Séquence d'ADN des produits de fusion résultant de la translocation chromosomique récurrente t(11;22) (q24;q12) associée au développement d'un groupe de tumeurs cancéreuses.
US5667981A (en) * 1994-05-13 1997-09-16 Childrens Hospital Of Los Angeles Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein
DE4444969C1 (de) * 1994-12-16 1996-10-24 Orga Med Dr Med Erwin Klopfer Nachweis von Antikörpern gegen p53 in Körperflüssigkeiten
US6150110A (en) * 1998-02-28 2000-11-21 The Brigham And Women's Hospital, Inc. HMGI(Y)-LAMA4* fusion oncogene, oncoprotein and methods of use

Also Published As

Publication number Publication date
ES2217558T3 (es) 2004-11-01
DK0983510T3 (da) 2004-07-05
US6610498B1 (en) 2003-08-26
EP0983510A1 (de) 2000-03-08
WO1998053317A1 (en) 1998-11-26
EP0983510B1 (de) 2004-03-03
DE69822149T2 (de) 2005-03-03
DE69822149D1 (de) 2004-04-08
AU7677198A (en) 1998-12-11
CA2290656A1 (en) 1998-11-26
PT983510E (pt) 2004-06-30
CA2290656C (en) 2008-01-15

Similar Documents

Publication Publication Date Title
IL138497A0 (en) Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
EP1217377A3 (de) Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens 2 verschiedenen molekularen Markern
WO2000077260A8 (en) Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
WO2001018252A3 (en) Methods for disease detection
ATE466930T1 (de) Universelles sammelmedium
EP1035215A3 (de) Verfahren und Sondenset zur Erkennung von Krebs
ATE278946T1 (de) Elektrochemischer biosensor-teststreifen mit erkennungselektrode und auslesemessgerät, das diesen teststreifen verwendet
DE60214134D1 (de) Modifizierte psma-liganden und deren verwendung
DE69528653D1 (de) Genetische diagnose und pharmazeutische produkte zur behandlung von prostatakrebs
WO2002086448A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
ATE318147T1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
ATE475097T1 (de) Erkennung von tumor-spezifischen genprodukten bei krebs
BR9916840A (pt) Sistema de detecção biológica portátil integrado
Große et al. Label-free imaging and spectroscopic analysis of intracellular bacterial infections
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
DE69822149D1 (de) Erkennung von tmorspezifische genprodukte
Oh et al. Rapid serial immunoprofiling of the tumor immune microenvironment by fine needle sampling
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
RS20100249A (en) CONJUGATES AND PROCEDURES FOR THEIR PRODUCTION, AND THEIR USE FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANE
DE69734595D1 (de) Verfahren zum entdecken von telomerase-aktivität
ATE404676T1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
BR9708256A (pt) Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo
Yang et al. Proximity-Guaranteed DNA Machine for Accurate Identification of Breast Cancer Extracellular Vesicles
Prabhakar et al. Cancer Diagnostics and Therapeutics
DK1042349T3 (da) Anvendelse af polyamid-nukleinsyre-oligomerer til frembringelse af et biologisk respons

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0983510

Country of ref document: EP